Vortioxetine (trade name Brintellix and Trintellix in Canada) is an atypical antidepressant (a serotonin modulator and stimulator) made by Lundbeck and Takeda. On September 30, 2013, it was approved by the U.S. FDA for the treatment of major depressive disorder (MDD) in adults. Vortioxetine was also investigated as a treatment for generalized anxiety disorder (GAD) but was not found to be superior to placebo.

Following a positive opinion by the Committee for Medicinal Products for Human Use (CHMP) in October 2013, Lundbeck announced December 27, 2013, that European marketing authorization for Brintellix had been obtained. More: en.wikipedia.org.

Your rating:
choose
 see voting results
1 opinions, 0 replies
Add your opinion:
Preview:
(mouse over or touch to update)
Item ID:
OK
Add your opinion
0
opinion
0 votes
Oct 3, 2015

Brintellix is just another dud antidepressant made by Lundbeck. I took it for 3 weeks. Side effects were terrible, the antidepressive effect very doubtful. There is nothing new about this drug. Just another drug poisoning people and bringing money to pharmaceutical companies.

reply
subscribe
share/challenge
flag
Add your opinion
Challenge someone to answer this topic:
Invite an OpiWiki user:
OR
Invite your friend via email:
OR
Share it: